FirstCry-Backed Swara Baby Products Secures SEBI Approval for Rs 1,000 Crore IPO

Disposable hygiene product manufacturer Swara Baby Products has received regulatory clearance from the Securities and Exchange Board of India (SEBI) to launch its initial public offering (IPO) aimed at raising Rs 1,000 crore. The company, backed by FirstCry parent Brainbees Solutions Limited, had submitted its draft red herring prospectus (DRHP) to the market regulator in July.

Issue Structure and Selling Shareholders

The planned Rs 1,000 crore public issue is split evenly between fresh equity and secondary share sales:

• Fresh Issue: Equity shares aggregating up to Rs 500 crore.
• Offer for Sale (OFS): Shares worth up to Rs 500 crore from existing promoter and investor entities.

Under the OFS component, Brainbees Solutions Limited will offload shares worth up to Rs 300 crore, while promoter entity Anadya Bon Merchari LLP will divest equity valued at up to Rs 200 crore. The company may also explore a pre-IPO placement of up to Rs 100 crore in consultation with its book-running lead managers, which could reduce the fresh issue size accordingly.

JM Financial and Avendus Capital have been appointed as the book-running lead managers for the issue.

Proposed Utilisation of Proceeds

According to the draft papers, the company has earmarked the net proceeds from the fresh issue across core operational and capital requirements:

• Manufacturing Expansion: Rs 198.2 crore to establish a new manufacturing facility in Madhya Pradesh.
• Debt Reduction: Rs 100 crore to prepay or repay certain outstanding borrowings.
• Subsidiary Debt Repayment: Rs 27.5 crore to be injected into subsidiaries—Solis Hygiene, Swara Hygiene, and K.A. Enterprises Hygiene Pvt Ltd (KAEHPL)—to clear their respective outstanding liabilities.
• Growth and General Purposes: The remaining capital will fund inorganic growth opportunities via strategic acquisitions and support general corporate requirements.

Business Operations and Market Position

Founded in 2018, Swara Baby Products operates across baby care, adult incontinence, and feminine hygiene verticals. Its manufacturing portfolio includes baby tape-style and pant-style diapers, adult diapers, sanitary napkins, and panty liners.

While it operates primarily as a business-to-business contract manufacturer for major brands—including Brainbees Solutions, Piramal Pharma, and Himalaya Wellness Company—it also retails proprietary labels, selling baby diapers under the Cuddles brand and adult diapers under the Shield brand. The company maintains four production facilities across Indore and Pithampur in Madhya Pradesh.

In FY25, Swara Baby was ranked as India's largest hygiene contract manufacturer by value. The draft prospectus highlights that the company commanded a 37% market share by value in India's baby diaper contract manufacturing sector and an estimated 36% market share in adult diaper contract manufacturing.

Financial Snapshot

The company has demonstrated consistent top-line and bottom-line expansion in recent financial years:

• Revenue from Operations: Grew 23.4% year-on-year to Rs 1,163.9 crore in FY26, up from Rs 942.97 crore in FY25.
• Net Profit: Profit after tax rose 18.5% to Rs 95.58 crore in FY26 compared to Rs 80.67 crore in FY25.
• Operating EBITDA: Stood at Rs 192.77 crore in FY26, improving from Rs 162.72 crore in the previous fiscal year.

Baby diapers remained the primary revenue driver for the business, contributing approximately 79% of total product sales during FY26.

Tags: Swara Baby Products Brainbees Solutions FirstCry SEBI IPO Indian Stock Market